Role of Iliotibial Band Stiffness in Perceived Leg Length Discrepancy After Total Hip Arthroplasty

February 19, 2026 updated by: Ankara Etlik City Hospital

The Role of Iliotibial Band Stiffness Assessed by Shear-Wave Elastography in Objective and Perceived Leg Length Discrepancy After Total Hip Arthroplasty

Patients undergoing total hip arthroplasty (THA) may experience objective or perceived leg length discrepancy (LLD/PLLD), which can negatively affect gait, pelvic balance, and patient satisfaction.

The iliotibial band (ITB) plays a critical role in lateral thigh tension transmission, and alterations in its stiffness may influence the perception of limb length discrepancy.

Shear-wave elastography (SWE) is a noninvasive ultrasound-based technique that enables quantitative assessment of soft tissue stiffness.

This cross-sectional observational study aims to investigate the relationship between ITB stiffness measured by SWE and both radiographic and perceived leg length discrepancy in adult patients who underwent unilateral primary THA at least 12 months previously.

Study Overview

Detailed Description

This study will include adult patients aged 18-90 years who underwent unilateral primary total hip arthroplasty at least 12 months prior to enrollment.

Patients will undergo clinical evaluation, functional scoring, radiographic assessment, and bilateral ITB stiffness measurement using shear-wave elastography.

Radiographic leg length discrepancy will be assessed using previously obtained pelvis AP and full-leg length radiographs without additional imaging exposure.

Perceived leg length discrepancy will be evaluated using a block test during standing examination.

ITB stiffness will be measured bilaterally at standardized anatomical landmarks using SWE by two experienced radiologists.

The primary aim is to assess correlations between ITB stiffness and radiographic LLD, as well as perceived LLD. Secondary analyses will evaluate whether ITB stiffness predicts PLLD independently of radiographic LLD.

Study Type

Observational

Enrollment (Actual)

68

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yenimahalle
      • Ankara, Yenimahalle, Turkey (Türkiye), 06170
        • Ankara Etlik City Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients who underwent total hip arthroplasty and had a minimum follow-up of at least 1 year were included in the study.

Description

Inclusion Criteria:

Age between 18 and 90 years History of unilateral primary TKA, with no prior revision surgery At least 12 months after surgery and returned to functional weight-bearing No use of walking aids, or use of a cane only for outdoor ambulation

Exclusion Criteria:

Bilateral TKA or severe osteoarthritis in the contralateral hip History of femoral, tibial, or hip surgery resulting in limb length-altering deformity Significant scoliosis (>20° Cobb angle) or pelvic obliquity >5° Neurological disorders (e.g., severe polyneuropathy, hemiparesis) History of lateral thigh surgery (e.g., IT band release, TFL surgery) Body mass index (BMI) >40 (may reduce the reliability of SWE measurements) Suspected prosthetic joint infection or implant instability

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Postoperative Follow-up Cohort
Patients who underwent surgery and were followed as part of routine postoperative care. Clinical scores and radiographic assessments were recorded during follow-up. Non-interventional ultrasound evaluation was performed in patients who had completed at least 12 months after surgery; some patients were assessed at longer postoperative intervals.
Non-interventional ultrasound performed during routine follow-up.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Harris Hip Score
Time Frame: At least 12 months postoperatively
At least 12 months postoperatively
Oxford Hip Score
Time Frame: At least 12 months postoperatively
At least 12 months postoperatively
HOOS score
Time Frame: At least 12 months postoperatively
Hip Disability and Osteoarthritis Outcome Score
At least 12 months postoperatively

Secondary Outcome Measures

Outcome Measure
Time Frame
leg length difference
Time Frame: At least 12 months postoperatively
At least 12 months postoperatively

Other Outcome Measures

Outcome Measure
Time Frame
iliotibial band tension-elastogram
Time Frame: At least 12 months postoperatively
At least 12 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 14, 2026

Primary Completion (Actual)

February 12, 2026

Study Completion (Actual)

February 17, 2026

Study Registration Dates

First Submitted

February 19, 2026

First Submitted That Met QC Criteria

February 19, 2026

First Posted (Actual)

February 24, 2026

Study Record Updates

Last Update Posted (Actual)

February 24, 2026

Last Update Submitted That Met QC Criteria

February 19, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • AEŞH-BADEK1-2025-581

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arthroplasty, Replacement, Hip

Clinical Trials on Shear-Wave Elastography (Ultrasound)

Subscribe